Timo Gaber

4.4k total citations
92 papers, 3.3k citations indexed

About

Timo Gaber is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, Timo Gaber has authored 92 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 29 papers in Rheumatology and 19 papers in Molecular Biology. Recurrent topics in Timo Gaber's work include Osteoarthritis Treatment and Mechanisms (14 papers), Immune cells in cancer (13 papers) and Immune Cell Function and Interaction (10 papers). Timo Gaber is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (14 papers), Immune cells in cancer (13 papers) and Immune Cell Function and Interaction (10 papers). Timo Gaber collaborates with scholars based in Germany, Switzerland and Poland. Timo Gaber's co-authors include Frank Buttgereit, Cindy Strehl, Georg N. Duda, Carsten Perka, Paula Hoff, Paula Kolar, Gerd‐Rüdiger Burmester, Alexandra Damerau, Katharina Schmidt‐Bleek and Lisa Ehlers and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Timo Gaber

87 papers receiving 3.3k citations

Peers

Timo Gaber
Timo Gaber
Citations per year, relative to Timo Gaber Timo Gaber (= 1×) peers Gunilla Westergren‐Thorsson

Countries citing papers authored by Timo Gaber

Since Specialization
Citations

This map shows the geographic impact of Timo Gaber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Gaber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Gaber more than expected).

Fields of papers citing papers by Timo Gaber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Gaber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Gaber. The network helps show where Timo Gaber may publish in the future.

Co-authorship network of co-authors of Timo Gaber

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Gaber. A scholar is included among the top collaborators of Timo Gaber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Gaber. Timo Gaber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Daniel J., Jens Klotsche, Carsten Perka, et al.. (2025). Fracture Fusion on Fast‐Forward: Locally Administered Deferoxamine Significantly Enhances Fracture Healing in Animal Models: A Systematic Review and Meta‐Analysis. Advanced Science. 12(8). e2413290–e2413290.
2.
Pfeiffenberger, Moritz, Alexandra Damerau, Johannes Plank, et al.. (2025). A Modular Perfusion Bioreactor Platform for Simulating Bone Regeneration and Fracture Healing: Integrating Mechanical Loading and Dual Perfusion for Advanced In Vitro Models. Advanced Healthcare Materials. 14(32). e02492–e02492.
3.
Damerau, Alexandra, Kasper Renggli, Moritz Pfeiffenberger, et al.. (2024). Microphysiological System‐Generated Physiological Shear Forces Reduce TNF‐α‐Mediated Cartilage Damage in a 3D Model of Arthritis. Advanced Science. 12(7). e2412010–e2412010.
4.
Damerau, Alexandra, Marieluise Kirchner, Philipp Mertins, Frank Buttgereit, & Timo Gaber. (2024). A point-of-research decision in synovial tissue engineering: Mesenchymal stromal cells, tissue derived fibroblast or CTGF-mediated mesenchymal-to-fibroblast transition. European Journal of Cell Biology. 103(4). 151455–151455. 3 indexed citations
5.
Kollert, Florian, et al.. (2023). Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial). Frontiers in Immunology. 14. 1165758–1165758. 6 indexed citations
6.
Lange, Tanja, et al.. (2023). Detecting and exploiting the circadian clock in rheumatoid arthritis. Acta Physiologica. 239(2). e14028–e14028. 2 indexed citations
7.
Damerau, Alexandra, Marieluise Kirchner, Moritz Pfeiffenberger, et al.. (2022). Metabolic reprogramming of synovial fibroblasts in osteoarthritis by inhibition of pathologically overexpressed pyruvate dehydrogenase kinases. Metabolic Engineering. 72. 116–132. 17 indexed citations
8.
Ehlers, Lisa, Alexandra Damerau, Marieluise Kirchner, et al.. (2021). Surface AMP deaminase 2 as a novel regulator modifying extracellular adenine nucleotide metabolism. The FASEB Journal. 35(7). e21684–e21684. 6 indexed citations
9.
Pfeiffenberger, Moritz, Alexandra Damerau, Thomas Buttgereit, et al.. (2021). Production of IL-6 and Phagocytosis Are the Most Resilient Immune Functions in Metabolically Compromised Human Monocytes. Frontiers in Immunology. 12. 730672–730672. 7 indexed citations
10.
Pfeiffenberger, Moritz, Alexandra Damerau, Igor Ponomarev, et al.. (2020). Functional Scaffold-Free Bone Equivalents Induce Osteogenic and Angiogenic Processes in a Human In Vitro Fracture Hematoma Model. Journal of Bone and Mineral Research. 36(6). 1189–1201. 9 indexed citations
11.
Ponomarev, Igor, et al.. (2018). Simulating osteoarthritis in vitro with human scaffold-free 3D cartilage transplants. Osteoarthritis and Cartilage. 26. S103–S103. 2 indexed citations
12.
Damerau, Alexandra, et al.. (2017). FRI0002 Development of an in vitro multi-component 3d joint model to simulate the pathogenesis of arthritis. Annals of the Rheumatic Diseases. 76. 480–480. 2 indexed citations
13.
Gaber, Timo, Korneliusz Miksch, Frank Buttgereit, et al.. (2017). Plant-derived pectin nanocoatings to prevent inflammatory cellular response of osteoblasts following <em>Porphyromonas gingivalis</em> infection. International Journal of Nanomedicine. Volume 12. 433–445. 12 indexed citations
14.
Gaber, Timo, et al.. (2016). Trace element and cytokine concentrations in patients with Fibrodysplasia Ossificans Progressiva (FOP): A case control study. Journal of Trace Elements in Medicine and Biology. 39. 186–192. 12 indexed citations
15.
Gaber, Timo, M. Hahne, Cindy Strehl, et al.. (2015). Disentangling the effects of tocilizumab on neutrophil survival and function. Immunologic Research. 64(3). 665–676. 13 indexed citations
16.
Kluge, Reinhart, et al.. (2015). Porphyromonas gingivalis Suppresses Differentiation and Increases Apoptosis of Osteoblasts From New Zealand Obese Mice. Journal of Periodontology. 86(9). 1095–1102. 14 indexed citations
17.
Strehl, Cindy, Timo Gaber, Manuela Jakstadt, et al.. (2013). High-Sensitivity Immunofluorescence Staining: A Comparison of the Liposome Procedure and the FASER Technique on mGR Detection. Journal of Fluorescence. 23(3). 509–518. 8 indexed citations
18.
Hoff, Paula, Frank Buttgereit, Gerd‐Rüdiger Burmester, et al.. (2012). Osteoarthritis synovial fluid activates pro-inflammatory cytokines in primary human chondrocytes. International Orthopaedics. 37(1). 145–151. 92 indexed citations
19.
Kolar, Paula, Timo Gaber, Carsten Perka, Georg N. Duda, & Frank Buttgereit. (2011). Human Early Fracture Hematoma Is Characterized by Inflammation and Hypoxia. Clinical Orthopaedics and Related Research. 469(11). 3118–3126. 154 indexed citations
20.
Kolar, Paula, Katharina Schmidt‐Bleek, Hanna Schell, et al.. (2010). The Early Fracture Hematoma and Its Potential Role in Fracture Healing. Tissue Engineering Part B Reviews. 16(4). 427–434. 304 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026